Theratechnologies Inc.: Mexico Approves the 1mg/vial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Theratechnologies Inc.: Mexico Approves the 1mg/vial Presentation of EGRIFTA(R) (tesamorelin for injection)

MONTREAL, CANADA--(Marketwired - March 8, 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that COFEPRIS, Mexico's health agency, has approved the 1mg/vial presentation of tesamorelin for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy, allowing the commercialization of EGRIFTA ® in this territory.

The approval of the 1mg/vial presentation comes in the footsteps of the 2mg/vial presentation approval which was received last July from Mexico' s health agency.

"We are very excited by this news especially since it is the result of a long process. We have reached another important milestone towards our goal to offer EGRIFTA ® to patients who are looking for a product addressing their condition. Our partner can now focus on the next steps in Mexico consisting in seeking reimbursement for the product and commercializing it," said Luc Tanguay, President and CEO, Theratechnologies Inc.

EGRIFTA ® was first approved by the United States Food and Drug Administration in November 2010 and by Health Canada in March 2015.

About Theratechnologies

Theratechnologies (TSX:TH) is a specialty pharmaceutical company addressing unmet medical needs in metabolic disorders to promote healthy ageing and an improved quality of life. Further information about Theratechnologies is available on the Company's website at www.theratech.com and on SEDAR at www.sedar.com

Forward-Looking Information

This press release contains forward-looking statements and forward-looking information, or, collectively, forward-looking statements, within the meaning of applicable securities laws, that are based on our management's belief and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as "may", "will", "should", "could", "would", "outlook", "believe", "plan", "envisage", "anticipate", "expect" and "estimate", or the negatives of these terms, or variations of them. The forward-looking statements contained in this press release include, but are not limited to, statements regarding the commercialization of EGRIFTA ® in Mexico.

Forward-looking statements are based upon a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond Theratechnologies' control that could cause actual results to differ materially from those that are disclosed in or implied by such forward-looking information. These assumptions include but are not limited to, the following: EGRIFTA ® will be accepted by the Mexican marketplace and will be on the list of reimbursed drugs in that country by third-party payors and the Mexican authorities. These risks and uncertainties include, but are not limited to, the risk that EGRIFTA ® is not accepted by the Mexican marketplace as a drug to treat lipodystrophy and the risk that EGRIFTA ® is not reimbursed by third party payors and the Mexican authorities.

We refer potential investors to the "Risk Factors" section of our Annual Information Form dated February 24, 2016 available on SEDAR at www.sedar.com . The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward-looking statements. Forward-looking statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date.

We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise, except as may be required by applicable law.

Denis Boucher EXOCET Public Relations inc. 514-913-1957
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peñoles Locks In Solar Storage for Northern Mine Loads

Updated Category News Views 33

A mine never sleeps, which is why the battery matters more than the solar-panel headline. Peñoles has signed a 20-year power-supply agreement with Atlas Renewable Energy for a Coahuila project combining 269 MWp of solar generation with battery storage. The project is slated to begin operating in the first half of 2029 and is expected to provide roughly 550 GWh a year to...

Continue Reading
Tonum and Euvita Link Supplements to Personalized Care

Updated Category News Views 14

Muscle loss has become the awkward footnote in the GLP-1 weight-loss boom, and Tonum Health is trying to put that concern nearer the center of the care conversation. Its newly announced partnership with euvita health places Tonum's supplements and functional nutrition products inside a physician-led platform built around biomarker testing, hormone and peptide therapy,...

Continue Reading
Blue Diamond's $1 Billion Brand Meets Farm Realities

Updated Category News Views 76

A Ten-Cent Signal Carries Real Weight A ten-cent edge over the industry benchmark may not excite the cocktail-party crowd, but almond growers notice every penny when fertilizer, power and pest control keep gnawing at the farm gate. Blue Diamond Growers says it delivered payments roughly 10 cents above the benchmark in its latest year, alongside net profit that came in...

Continue Reading
Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 110

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading
Dario’s Second Women’s Health Win Tests Expansion Case

Updated Category News Views 71

Midlife care just became the newest proving ground for DarioHealth’s sales pitch. The company says The Minnesota Star Tribune has expanded its existing relationship to include Dario Women™, a program for employees navigating perimenopause and menopause. Eligible employees are expected to gain access in January 2027. For NASDAQ:DRIO, this is not some grand revenue...

Continue Reading
Hone Health’s $228M Bet on Data-Led Longevity Care

Updated Category News Views 172

Longevity medicine just got a very large check and an even larger assignment. Hone Health says it has raised $228 million to push physician-led care beyond its roots in hormone optimization, and the split of that financing matters more than the celebrity names attached to it. Only $28 million is described as Series A equity; the other $200 million comes as growth...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 59

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Devicie Broadens Browser Security Across Device Fleets

Updated Category News Views 23

Browsers have quietly become the front door, side door, and occasionally the busted basement window of corporate security. Devicie’s newly expanded Edge for Business Reporting Connector tackles that uncomfortable reality by pulling browser security events from Windows, macOS, iOS, and Android into the same console customers use to oversee Microsoft Intune environments....

Continue Reading
Another Nine's A9OS Puts Software at Center of Golf

Updated Category News Views 63

A golf simulator chain is trying to turn the boring plumbing into its sharpest club. Another Nine’s A9OS is not merely a booking widget dressed up for a franchise brochure; it is meant to run the whole 24/7 operation, from payments and door access to cameras, simulator support and guest help. That ambition deserves attention because this is exactly where a staff-free...

Continue Reading
SteriLance Aims for Smoother Pricks with NanoSense Move

Updated Category News Views 92

Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...

Continue Reading

Top 5 Most Recently Viewed Articles

Gamma Communications Celebrated for UCaaS Competitive Strategy

Updated Category News Views 342

Gamma Communications Receives Frost & Sullivan Recognition Gamma Communications has received prestigious recognition from Frost & Sullivan with the 2024 Competitive Strategy Leadership Award in the European unified communications as a service (UCaaS) industry. This award highlights the company’s exceptional strategy execution, innovative approaches, and impressive...

Continue Reading
ConocoPhillips Reports Strong Q3 2025 Results and Outlook

Updated Category News Views 232

ConocoPhillips Delivers Strong Third Quarter Performance ConocoPhillips (NYSE: COP) has once again demonstrated its robust operational capacity, reporting impressive financial results for the third quarter. Beginning with consistent execution across its production portfolio, the company's recent performance has exceeded market expectations, showcasing a continued...

Continue Reading
Electrosurgery Generators Market Set to Surge by $3.3 Billion

Updated Category News Views 125

Electrosurgery Generators Market Overview The global electrosurgery generators market is on an impressive growth trajectory, projected to reach USD 3,359.2 million by 2035. As healthcare evolves, this market is driven by innovations and a rising preference for minimally invasive procedures. The surge in outpatient surgical centers and advancements in electrosurgical...

Continue Reading
Explore the Versatile Applications of INNOVERA™ at Lineapelle Milan

Updated Category News Views 322

Discover INNOVERA™ at Lineapelle Milan 2026 Modern Meadow, a pioneer in bio-design, is set to showcase their groundbreaking material, INNOVERA™, at the highly anticipated Lineapelle Milan 2026. This prominent international leather fair will provide a platform for the company to illustrate the dynamic capabilities of INNOVERA™ across various industries. A Revolution...

Continue Reading
Harnessing AI for Enhanced Military Logistics Efficiency

Updated Category News Views 174

Virtualitics Secures Phase II Contract with AFGSC Virtualitics has recently been awarded a significant contract with the U.S. Air Force Global Strike Command (AFGSC). This Small Business Innovation Research (SBIR) Phase II contract aims to optimize logistics using artificial intelligence (AI) for Readiness Spares Package (RSP) mobilization. This initiative is crucial to...

Continue Reading